Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Siemens Healthineers AG is a global medical technology company specializing in diagnostic and therapeutic solutions for healthcare providers. The company operates primarily in the medical imaging, diagnostics, advanced therapies, and digital health industries, serving hospitals, outpatient clinics, and research institutions. Its core revenue drivers include imaging systems, in vitro diagnostics equipment, and clinical therapy systems, complemented by software, services, and digital solutions that support clinical decision-making and operational efficiency.
The company originated as part of Siemens AG’s healthcare business, with roots dating back to the late 19th century through Siemens’ involvement in medical imaging and electrical engineering. Siemens Healthineers was established as a separate legal entity in 2017 and subsequently listed publicly in 2018, while Siemens AG remains a majority shareholder. The company’s positioning is centered on integrated diagnostics and therapy ecosystems, leveraging scale, long-term customer relationships, and a broad installed base to support recurring service and software revenues.
Business Operations
Siemens Healthineers operates through several major business segments, including Imaging, Diagnostics, Advanced Therapies, and Varian, which focuses on radiation oncology following its acquisition. The Imaging segment encompasses magnetic resonance, computed tomography, X-ray, and molecular imaging systems. Diagnostics includes laboratory diagnostics, point-of-care testing, and molecular diagnostics. Advanced Therapies provides image-guided therapy systems used in minimally invasive procedures, while Varian delivers integrated cancer care solutions such as radiotherapy and oncology software.
The company generates revenue through the sale of medical equipment, long-term service contracts, consumables, and software licenses. Operations are supported by a combination of in-house manufacturing, proprietary software platforms, and a global service network. Siemens Healthineers controls key technologies in imaging hardware, diagnostics automation, and clinical software, and operates through numerous wholly owned subsidiaries worldwide, including Varian Medical Systems, Inc. as a significant operating unit.
Strategic Position & Investments
Strategically, Siemens Healthineers focuses on expanding its role across the patient care continuum, from early detection and diagnosis to treatment and follow-up care. Growth initiatives emphasize precision medicine, digitalization, and integrated diagnostics, alongside operational efficiency and margin improvement. The acquisition of Varian Medical Systems, Inc. significantly expanded the company’s oncology portfolio and positioned it as a comprehensive cancer care provider.
The company continues to invest in emerging technologies such as artificial intelligence for imaging and diagnostics, automation in laboratories, and data-driven clinical decision support. It also maintains strategic partnerships with healthcare providers and research institutions to co-develop solutions and validate new technologies. Investments are typically aligned with long-term healthcare trends, including aging populations and increasing demand for value-based care.
Geographic Footprint
Siemens Healthineers is headquartered in Germany and maintains a global operational presence across Europe, North America, Asia-Pacific, Latin America, and parts of Africa and the Middle East. The company derives a substantial portion of its revenue from North America and Europe, with Asia-Pacific representing a key growth region due to expanding healthcare infrastructure and rising diagnostic demand.
Manufacturing, research and development, sales, and service operations are distributed globally, enabling proximity to key markets and customers. Through its international subsidiaries and regional headquarters, Siemens Healthineers maintains strong market positions in both developed and emerging economies, supporting a diversified revenue base and global customer reach.
Leadership & Governance
Siemens Healthineers is led by an experienced executive team with backgrounds in healthcare technology, engineering, and global operations. Governance reflects its status as a publicly listed company with a majority shareholder, balancing independence with strategic alignment to Siemens AG. Leadership emphasizes long-term value creation, technological innovation, and sustainable growth in global healthcare markets.
Key executives include:
- Bernd Montag – Chief Executive Officer
- Jochen Schmitz – Chief Financial Officer
- Elisabeth Staudinger – Member of the Managing Board, Diagnostics
- Christian Lovis – Member of the Managing Board, Digital Health
- Arthur W. van der Merwe – Chief Human Resources Officer